Mario Rivas - Jan 1, 2023 Form 4 Insider Report for Transphorm, Inc. (TGAN)

Role
Chief Executive Officer, Director
Signature
/s/ Cameron McAulay, Attorney-in-Fact
Stock symbol
TGAN
Transactions as of
Jan 1, 2023
Transactions value $
-$68,180
Form type
4
Date filed
1/4/2023, 03:08 PM
Previous filing
Nov 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TGAN Common Stock Award $0 +16.5K +14% $0.00 135K Jan 1, 2023 Direct F1
transaction TGAN Common Stock Tax liability -$68.2K -12.5K -9.3% $5.44 122K Jan 1, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a Restricted Stock Unit ("RSU"). 100% of the RSUs will vest on January 1, 2024, subject to the Reporting Person's continued status as a Service Provider to the Issuer through that vesting date.
F2 The reported shares were withheld to cover the Reporting Person's tax liability in connection with the vesting of RSUs.